Parameters | N (%) |
---|---|
Age (years) | |
51-70 | 36 (31) |
71-75 | 40 (34) |
76-84 | 41 (35) |
Clinical stage | |
T1b | 1 (1) |
T1c | 18 (15) |
T2a | 27 (23) |
T2b | 21 (18) |
T2c | 50 (43) |
PSA (ng/ml) | |
0-10.0 | 33 (28) |
10.1-20.0 | 42 (36) |
>20.0 | 42 (36) |
Gleason score | |
4 | 3 (3) |
5 | 13 (11) |
6 | 53 (45) |
7 | 31 (26) |
8 | 12 (10) |
9 | 5 (4) |
Prostate volume | |
≥30 ml | 53 (45) |
<30 ml | 64 (55) |
PPC | |
<0.5 | 69 (59) |
≥0.5 | 48 (41) |
EBRT | |
Yes | 6 (5) |
No | 111 (95) |
D 90 | |
≥140 | 78 (70) |
<140 | 33 (30) |